Wird geladen...

CDK4/6 inhibition enhances pulmonary inflammatory infiltration in bleomycin-induced lung fibrosis

Inhibitors of cyclin-dependent kinases 4/6 (CDK4/6) block cell cycle progression and are commonly used for treatment of several forms of cancer. Due to their anti-proliferative mode of action, we hypothesized that palbociclib could attenuate the development of bleomycin-induced lung fibrosis. In a p...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Respir Res
Hauptverfasser: Birnhuber, Anna, Egemnazarov, Bakytbek, Biasin, Valentina, Bonyadi Rad, Ehsan, Wygrecka, Malgorzata, Olschewski, Horst, Kwapiszewska, Grazyna, Marsh, Leigh M.
Format: Artigo
Sprache:Inglês
Veröffentlicht: BioMed Central 2020
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7331186/
https://ncbi.nlm.nih.gov/pubmed/32616042
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12931-020-01433-w
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!